Advertisement
Screener

AMARIN CORP PLC\UK (AMRN) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

AMARIN CORP PLC\UK Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • AMARIN CORP PLC\UK return tang equity for the quarter ending 2026-06-30 was -6.29%, a change of 16.73% year-over-year.
  • AMARIN CORP PLC\UK return tang equity for the quarter ending 2026-03-31 was -7.70%, a change of 11.50% year-over-year.
  • AMARIN CORP PLC\UK return tang equity for the quarter ending 2025-12-31 was -8.70%, a change of 8.79% year-over-year.
  • AMARIN CORP PLC\UK return tang equity for the quarter ending 2025-09-30 was -19.38%, a change of -11.73% year-over-year.
  • AMARIN CORP PLC\UK return tang equity for fiscal 2025 was -8.70%, a change of 8.79% from fiscal 2024.
  • AMARIN CORP PLC\UK return tang equity for fiscal 2024 was -17.49%, a change of -6.40% from fiscal 2023.
  • AMARIN CORP PLC\UK return tang equity for fiscal 2023 was -11.09%, a change of 7.35% from fiscal 2022.
  • AMARIN CORP PLC\UK return tang equity for fiscal 2022 was -18.45%, a 1635.98% decline from fiscal 2021.
Available history
2009-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-30-6.29%-$27.12M$431.52M
2026-03-31-7.70%-$33.61M$436.69M
2025-12-31-8.70%-$38.8M$445.92M
2025-09-30-19.38%-$86.19M$444.83M
2025-06-30-23.02%-$103.59M$449.99M
2025-03-31-19.20%-$87.93M$458.03M
2024-12-31-17.49%-$82.18M$469.79M
2024-09-30-7.65%-$39.35M$514.26M
2024-06-30-6.28%-$33.52M$534.03M
2024-03-31-9.98%-$52.61M$527.36M
2023-12-31-11.09%-$59.11M$532.79M
2023-09-30-9.84%-$52.48M$533.47M
2023-06-30-6.98%-$38.3M$548.75M
2023-03-31-16.09%-$90.7M$563.72M
2022-12-31-18.45%-$105.8M$573.55M
2022-09-30-16.24%-$91.96M$566.19M
2022-06-30-17.92%-$99.97M$557.77M
2022-03-31-3.59%-$22.21M$618.2M
2021-12-311.20%$7.73M$643.55M
2021-09-30-0.33%-$2.04M$618.31M
2021-06-300.70%$4.32M$620.5M
2021-03-310.15%$927,000.00$609.16M
2020-12-31-2.93%-$18M$613.69M
2020-09-30-2.67%-$15.86M$593.08M
2020-06-30-2.13%-$12.53M$588.23M
2020-03-31-3.29%-$18.77M$570.88M
2019-12-31-3.82%-$22.65M$593.01M
2019-09-30-10.76%-$63.38M$588.9M
2019-06-30-59.46%-$84.39M$141.93M
2019-03-31-87.44%-$116.78M$133.55M
2018-12-31-80.39%-$116.45M$144.85M
2018-09-30174.04%-$105.24M-$60.47M
2018-06-30168.10%-$91.6M-$54.49M
2018-03-31288.45%-$71.02M-$24.62M
2017-12-3192.68%-$67.87M-$73.23M
2017-09-30133.93%-$72.85M-$54.4M
2017-06-30164.79%-$77.8M-$47.21M
2017-03-31207.39%-$77.52M-$37.38M
2016-12-31484.30%-$86.35M-$17.83M
2016-09-30-1293.85%-$80.79M$6.24M
2016-06-3055.15%-$95.69M-$173.51M
2016-03-3168.84%-$113.85M-$165.39M
2015-12-3183.11%-$115.2M-$138.61M
2015-09-3093.62%-$112.97M-$120.67M
2015-06-30107.17%-$108.35M-$101.09M
2015-03-3185.76%-$61.51M-$71.73M
2014-12-3157.22%-$56.36M-$98.51M
2014-09-3065.59%-$52.12M-$79.47M
2014-06-30124.17%-$74.95M-$60.36M
2014-03-31190.85%-$130.05M-$68.14M
2013-12-31373.00%-$166.23M-$44.57M
2013-09-30564.93%-$161.38M-$28.57M
2013-06-30131.85%-$138.93M-$105.37M
2013-03-31214.73%-$153.06M-$71.28M
2012-12-311167.16%-$179.18M-$15.35M
2012-09-30-395465.79%-$150.28M$38,000.00
2012-06-30-517.03%-$27.51M$5.32M
2012-03-31-354.74%$228.5M-$64.41M
2011-12-31-5620.26%$335.08M-$5.96M
2011-09-30-425.02%$128.93M-$30.34M
2011-06-30-13.82%$21.38M-$154.72M
2011-03-31478.12%-$222.08M-$46.45M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-31-8.70%-$38.8M$445.92M
2024-12-31-17.49%-$82.18M$469.79M
2023-12-31-11.09%-$59.11M$532.79M
2022-12-31-18.45%-$105.8M$573.55M
2021-12-311.20%$7.73M$643.55M
2020-12-31-2.93%-$18M$613.69M
2019-12-31-3.82%-$22.65M$593.01M
2018-12-31-80.39%-$116.45M$144.85M
2017-12-3192.68%-$67.87M-$73.23M
2016-12-31484.30%-$86.35M-$17.83M
2015-12-3183.11%-$115.2M-$138.61M
2014-12-3157.22%-$56.36M-$98.51M
2013-12-31373.00%-$166.23M-$44.57M
2012-12-311167.17%-$179.18M-$15.35M
2011-12-311159.44%-$69.13M-$5.96M
2010-12-31123.33%-$249.59M-$202.37M
2009-12-31-463.94%-$30.61M$6.6M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Pulmatrix, Inc. (PULM)United States$0.006B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Ernexa Therapeutics Inc. (ERNA)United States$0.006B